Skip to main content
OpenTrials

Clinical trial condition

Ovarian Diseases

Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.

3,395 public trials 656 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Diseases trial results

Recruiting

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

NCT05887609

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • City of Hope Lennar Irvine, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • University of Pennsylvania Health System, Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Study of NTB-928 in R/R OC

NCT07690189

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • START Northwell, LLC Lake Success, New York, United States
  • Start Ccbd, Llc Fort Worth, Texas, United States
View Trial Details
Recruiting

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

NCT05281471

Conditions
Adnexal Diseases, DNA Virus Infections, Endocrine Gland Neoplasms, +26 more
Locations
  • The University of South Alabama, Mitchell Cancer Institute Mobile, Alabama, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health - Moores Cancer Center La Jolla, California, United States
View all 32 locations
View Trial Details
Recruiting

Using Aspirin to Improve Immunological Features of Ovarian Tumors

NCT05080946

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Virginia Comprehensive Cancer Center Charlottesville, Virginia, United States
  • Inova Schar Cancer Institute Fairfax, Virginia, United States
View Trial Details
Recruiting

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT06695845

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +64 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
  • Rocky Mountain Cancer Center Littleton, Colorado, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
View all 28 locations
View Trial Details
Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

NCT06787612

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC San Diego Health La Jolla, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 54 locations
View Trial Details

Related conditions